Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy.

Duke University Medical Center, Durham, NC, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Durham, NC
Treatments:ChemotherapyHospital:Duke University Medical Center
Drugs:Journal:Link
Date:Jul 2012

Description:

Patients:
This phase 2 study involved 74 women with recurrent, platinum-sensitive ovarian cancer. The median patient age was 64 years.

Treatment:
Patients were treated with a combination of the chemotherapy agents docetaxel and carboplatin.

Toxicities:
The most severe toxicities were of grade 4 and included neutropenia and thrombocytopenia. Grade 3 neurotoxicity was also reported.

Results:
The median overall survival was 33.2 months.

Support:
This study was supported by Sanofi-Aventis.

Correspondence: Dr. Angeles Alvarez Secord; email: secor002@mc.duke.edu



Back